S. Shapiro

First name
S.
Middle name
B.
Last name
Shapiro
Shapiro, S. B., Yin, H. ., H. Y. Yu, O. ., Rej, S. ., Suissa, S. ., & Azoulay, L. . (2025). Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. Bmj, 388, e080679. http://doi.org/10.1136/bmj-2024-080679
Shapiro, S. B., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2024). Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-024-01434-4
Shapiro, S. B., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.16039